Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,272 total articles
Next Technology Holding Inc. successfully closed a registered direct offering raising approximately $157 million through the sale of common stock and pre-funded warrants. The capital raise supports the company's dual-engine strategy combining AI-enabled SaaS solutions for industrial clients and leveraging digital assets including Bitcoin, positioni…
Iterum Therapeutics plc has filed a winding up petition in the Irish High Court, moving towards liquidation due to insufficient cash resources, inability to comply with Nasdaq listing requirements, lack of viable strategic alternatives, and ongoing financial pressures from operating costs including commercialization of ORLYNVAH™. The company antici…
Quantum BioPharma Ltd. granted 35,000 stock options to employees and consultants, exercisable at CA$6.50 for five years, as part of its ongoing efforts to incentivize staff amidst its development of innovative biopharmaceutical assets targeting neurodegenerative and metabolic disorders.
Palvella Therapeutics announced two poster presentations at the 2026 American Academy of Dermatology Annual Meeting highlighting advances in their rare skin disease pipeline. Key data include the innovative QTORIN™ rapamycin anhydrous gel formulation overcoming prior drug stability issues and positive Phase 3 results in microcystic lymphatic malfor…
XORTX Therapeutics Inc. announced the results of its annual and special shareholders meeting held on March 24, 2026. Key approvals included election of all five board nominees, appointment of auditors, re-approval of the stock option plan, and authorization of share consolidation. The company focuses on developing treatments for gout and progressiv…
STMicroelectronics has detailed the resolutions for its 2026 Annual General Meeting, including approval of the 2025 financial accounts, distribution of quarterly dividends, reappointment of board members, and authorizations for share repurchases and issuances. The company also highlighted its sustainability commitments and compliance with regulator…
Datacentrex, Inc., a digital infrastructure company operating Scrypt compute assets, has priced a confidentially marketed public offering of common stock and pre-funded warrants at $2.00 per share, expecting gross proceeds of approximately $20.17 million. The offering will close around March 30, 2026, with net proceeds intended for working capital …
QDRO Acquisition Corp., a blank check company focused on acquiring businesses in financial services, digital currency, and technology, has priced its initial public offering (IPO) at 20 million units priced at $10 each, totaling $200 million. The units include Class A shares and redeemable warrants, with trading beginning on Nasdaq under the ticker…
YPF SA, Argentina's largest energy company, has filed its annual Form 20-F for the fiscal year ended December 31, 2025, with the US Securities and Exchange Commission, including audited financial statements. The report is accessible on YPF's official website and the SEC website. As a major producer of oil and natural gas in Argentina, with signific…
DBV Technologies, a late-stage biopharmaceutical company focused on food allergy treatments, announced the filing of its 2025 Annual Report on Form 10-K with the U.S. SEC and the Universal Registration Document with the French market authority. The filings include comprehensive financial data, corporate governance reports, share buy-back informatio…
Rumble Inc., a Nasdaq-listed technology platform company, announced the appointment of Mike Masci as its new Chief Financial Officer effective March 31, 2026. Masci brings extensive experience from Intel in AI, cloud infrastructure, and financial leadership, positioning Rumble for growth as it scales its platform and pursues AI infrastructure oppor…
LeonaBio, a clinical-stage biotech company, reported its 2025 financial results highlighting the acquisition of lasofoxifene license for Phase 3 breast cancer trials, successful $90 million private financing with potential for $146 million additional funds, and pipeline progress including upcoming Phase 3 trial enrollment completion in metastatic b…
DBV Technologies reported full-year 2025 financial results highlighting advances in its VIASKIN Peanut Patch clinical development for peanut-allergic children and toddlers. The company strengthened its leadership in preparation for the Biologics License Application (BLA) submission for U.S. approval and secured significant financing to fund operati…
Future Money Acquisition Corporation has priced its initial public offering of 10 million units at $10 per unit, totaling $100 million, and will begin trading on Nasdaq under the ticker FMACU. The special purpose acquisition company (SPAC) is formed to identify and merge with businesses across any industry or geography, with completion expected by …
Nortech Systems Incorporated reported a profitable fourth quarter for 2025, achieving net income of $0.9 million compared to a loss in the prior year quarter. The company saw increased net sales to $30.3 million and significant improvement in EBITDA, reflecting successful strategic restructuring and operational efficiencies. Nortech also secured $1…
Auburn National Bancorporation, Inc. has expanded its Board of Directors to include Jeff Evans, who brings over 30 years of experience in property management, construction, and real estate. Evans is also nominated for reelection at the upcoming Annual Meeting of Shareholders. The company and its subsidiary, AuburnBank, operate primarily in East Ala…
Fortuna Mining Corp., a Canadian precious metals mining company, has filed its annual report on Form 40-F for the fiscal year ended December 31, 2025, with the U.S. Securities and Exchange Commission. The filing includes audited consolidated financial statements, management's discussion and analysis, and an annual information form. The company oper…
Sanuwave Health, Inc. reported record quarterly and annual revenues for Q4 and full year 2025, with revenues increasing 29.7% in Q4 and 35.0% for the full year compared to 2024. The company achieved improved adjusted EBITDA and net income, driven primarily by strong sales of its UltraMIST wound care systems and consumables. Despite some challenges …
KULR Technology Group, a designer and builder of advanced battery systems, scheduled its earnings call for the fourth quarter and full year ending December 31, 2025, to be held on March 31, 2026. The company will discuss financial results and take shareholder questions during the call.
XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company focused on therapies for gout and progressive kidney disease, announced a delay in the effective date of its 1-for-5 share consolidation from March 27, 2026, to April 6, 2026. The consolidation remains subject to necessary approvals from the TSX Venture Exchange and Nasdaq Stock …
Abundia Global Impact Group, Inc. announced its 2026 Annual Meeting of Stockholders to be held on May 14, 2026, and provided an update on its annual filings. The company disclosed that its audited financial statements for fiscal year 2025 included a going concern qualification from its independent auditor, highlighting uncertainties regarding its a…
Kornit Digital LTD., a leader in sustainable digital fashion and textile production, has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the U.S. Securities and Exchange Commission. The report includes audited financial statements accessible via the SEC and the company's investor relations website, with hard c…
Inspira Technologies reported its full year 2025 financial results, highlighting key milestones including initial commercial deployments of its INSPIRA ART100 life-support system generating early revenue, securing $49.5 million in binding purchase orders, and expanding clinical use in leading U.S. medical centers. The company also progressed its HY…
Disc Medicine has completed enrollment of the Phase 3 APOLLO trial for bitopertin, an investigational oral treatment for erythropoietic protoporphyria (EPP). The study was expanded from 150 to 183 participants due to high demand. Results are expected in Q4 2026, with subsequent regulatory engagement aimed at FDA approval potentially by mid-2027. Th…
CVB Financial Corp. and Heritage Commerce Corp. announced shareholder approval for their proposed merger. The transaction, pending regulatory approvals, is expected to close in the second quarter of 2026. The merger aims to combine two strong California-based banking organizations to enhance service offerings and achieve operational synergies.
